Fighting covid-19

DMO Campos, CBS Oliveira, JMA Andrade… - Brazilian Journal of …, 2020 - SciELO Brasil
The current COVID-19 pandemic caused by the novel coronavirus (SARS-CoV2) poses a
threat to global health owing to its high rate of spread and severe forms of respiratory …

Potential therapeutic and pharmacological strategies for SARS-CoV2

DA Ghareeb, SR Saleh, MS Nofal… - Journal of …, 2021 - Springer
Background At the end of 2019, the new Coronavirus disease 2019 (COVID-19) strain
causing severe acute respiratory syndrome swept the world. From November 2019 till …

COVID-19: A review on diagnosis, treatment, and prophylaxis

A Fierabracci, A Arena, P Rossi - International journal of molecular …, 2020 - mdpi.com
Coronavirus 2 (CoV) Severe Acute Respiratory Syndrome (SARS-CoV2) is causing a highly
infectious pandemic pneumonia. Coronaviruses are positive sense single-stranded RNA …

Clinical progress of therapeutics and vaccines: Rising hope against COVID-19 treatment

R Bandaru, SR Rout, OS Kamble, SK Samal… - Process …, 2022 - Elsevier
Cases of deaths due to COVID-19 (COrona VIrus Disease-19) infection are increasing
gradually worldwide. Immense research is ongoing to control this pandemic condition …

[HTML][HTML] Human endeavor for anti-SARS-CoV-2 pharmacotherapy: A major strategy to fight the pandemic

R Wang, P Stephen, Y Tao, W Zhang, SX Lin - Biomedicine & …, 2021 - Elsevier
The global spread of COVID-19 constitutes the most dangerous pandemic to emerge during
the last one hundred years. About seventy-nine million infections and more than 1.7 million …

A review of SARS-CoV-2 and the ongoing clinical trials

YF Tu, CS Chien, AA Yarmishyn, YY Lin… - International journal of …, 2020 - mdpi.com
The sudden outbreak of 2019 novel coronavirus (2019-nCoV, later named SARS-CoV-2) in
Wuhan, China, which rapidly grew into a global pandemic, marked the third introduction of a …

A review of SARS-CoV-2 and the ongoing clinical trials

T Yung-Fang, CS Chien, AA Yarmishyn… - International …, 2020 - search.proquest.com
The sudden outbreak of 2019 novel coronavirus (2019-nCoV, later named SARS-CoV-2) in
Wuhan, China, which rapidly grew into a global pandemic, marked the third introduction of a …

Current status of multiple drug molecules, and vaccines: an update in SARS-CoV-2 therapeutics

R Kandimalla, A John, C Abburi, J Vallamkondu… - Molecular …, 2020 - Springer
The coronavirus disease of 2019 (COVID-19) is a pandemic disease that has taken the lives
of many around the world. It is caused by severe acute respiratory syndrome-corona virus-2 …

[PDF][PDF] Covid-19: Towards confronting an unprecedented pandemic

T Kumari, V Shukla - International Journal of Biological Innovations, 2020 - academia.edu
Latest 73 report of COVID-19 from national authorities to WHO by April 2, 2020, there are
896450 confirmed cases with 45526 deaths globally. 0 to 14 days is the average range of …

Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection

G Krishna, VS Pillai, MV Veettil - European Journal of Pharmacology, 2020 - Elsevier
Virus onslaughts continue to spread fear and cause rampage across the world every now
and then. The twenty first century is yet again witnessing a gross global pandemic …